| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BeOne Medicines Ltd. | Chief Financial Officer | Ordinary Shares | 215K | $50.2M | $233.25 | 01 Aug 2025 | Direct |
| BeOne Medicines Ltd. | Chief Financial Officer | American Depositary Shares | 0 | $0 | $290.47 | 01 Aug 2025 | Direct |
| BeOne Medicines Ltd. | Chief Financial Officer | Share Option (Right to Buy) | 120K | 10 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ONC | BeOne Medicines Ltd. | 01 Aug 2025 | 1 | -$346K | 4 | Chief Financial Officer | 05 Aug 2025, 17:16 |
| ONC | BeOne Medicines Ltd. | 10 Jun 2025 | 2 | $0 | 4 | Chief Financial Officer | 12 Jun 2025, 17:45 |
| BGNE | BeiGene, Ltd. | 05 Mar 2025 | 1 | $0 | 4 | Chief Financial Officer | 07 Mar 2025, 19:19 |
| BGNE | BeiGene, Ltd. | 09 Aug 2024 | 2 | $0 | 4 | Chief Financial Officer | 13 Aug 2024, 17:17 |
| BGNE | BeiGene, Ltd. | 22 Jul 2024 | 0 | $0 | 3 | Chief Financial Officer | 24 Jul 2024, 17:23 |